At the 21st Meeting of Chongqing Lummy Pharmaceutical Co.Ltd(300006) the Fifth Board of directors held on the afternoon of December 30, Mr. Liang Jiansheng was unanimously elected as the chairman of the Fifth Board of directors of the company, and his term of office is the same as that of the Fifth Board of directors of the company, that is, from that day to June 11, 2023. At the second extraordinary general meeting of the company in 2021 held earlier, the proposal to nominate Liang Jiansheng as a non independent director of the company was passed by a high vote.
It is reported that after the above shareholders’ meeting, Peng Weimin, chairman of the company, submitted a written resignation report to the board of directors. He applied for resignation from the positions of chairman, director and chairman of the strategy committee due to work adjustment, and no longer held any position in the company after resignation.
According to the resume, Liang Jiansheng was born in October 1982, Chinese nationality, without overseas residency, graduate degree, political engineer and CPC member. He started work in July 2006 and once served as the party affairs business manager of the human resources department (Party Committee Office) of Guangxi Investment Group Co., Ltd; Deputy manager of human resources department and deputy director of Party Committee Office of Guangxi longxianggu Investment Co., Ltd; Deputy manager of human resources department and deputy director of Party Committee Office of Guangxi longxianggu Investment Co., Ltd. (presiding over the work); Deputy general manager of general management department of Guangxi Investment Group Financial Holding Co., Ltd. (presiding over the work); Deputy general manager of party masses work department of Guangxi Investment Group Co., Ltd. (deputy director of trade union office); He is currently Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) Deputy Secretary of the Party committee, director, chairman of the trade union and chairman of Guangxi Zhongheng traditional Chinese Medicine Industry Development Co., Ltd.
Up to now, Liang Jiansheng does not hold Chongqing Lummy Pharmaceutical Co.Ltd(300006) shares. He and the current non independent directors Ou Rihua, Hu Leibing and Tang Weiyan are appointed by the company’s controlling shareholder Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) and hold relevant positions in Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) or its subsidiaries. It is reported that this is the second chairman after Chongqing Lummy Pharmaceutical Co.Ltd(300006) change of ownership Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) , and the legal representative of the company will be changed to Liang Jiansheng.
In order to meet the development needs, give full play to the role of the general legal adviser in the legal review and control of operation and management, and promote the company’s legal operation and compliance management, the board of directors of the company also agreed to appoint Cui Dan, deputy general manager and Secretary of the board of directors, as the general legal adviser of the company, with a term of office consistent with the term of office of the Fifth Board of directors of the company.
(Shanghai Securities News · China Securities Network)
